Connection

CAROLYN SMITH to Humans

This is a "connection" page, showing publications CAROLYN SMITH has written about Humans.
Connection Strength

0.152
  1. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Res. 2014 Jun 18; 16(3):212.
    View in: PubMed
    Score: 0.013
  2. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20; 507(7492):315-22.
    View in: PubMed
    Score: 0.012
  3. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence. Breast Cancer Res Treat. 2012 Nov; 136(1):253-65.
    View in: PubMed
    Score: 0.011
  4. Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation. Horm Cancer. 2013 Feb; 4(1):24-35.
    View in: PubMed
    Score: 0.011
  5. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology. 2007 Jun; 69(6):1221-6.
    View in: PubMed
    Score: 0.008
  6. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators. Mol Endocrinol. 2006 Nov; 20(11):2695-710.
    View in: PubMed
    Score: 0.007
  7. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1339-44.
    View in: PubMed
    Score: 0.007
  8. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment. J Mol Endocrinol. 2004 Feb; 32(1):307-23.
    View in: PubMed
    Score: 0.006
  9. SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1. J Biol Chem. 2002 Jan 18; 277(3):1669-79.
    View in: PubMed
    Score: 0.005
  10. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001 Oct 01; 6:D1379-91.
    View in: PubMed
    Score: 0.005
  11. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther. 2000 Nov; 295(2):431-7.
    View in: PubMed
    Score: 0.005
  12. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. 1998 Sep; 48(9):956-60.
    View in: PubMed
    Score: 0.004
  13. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod. 1998 Mar; 58(3):627-32.
    View in: PubMed
    Score: 0.004
  14. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol. 1997 Jun; 11(6):657-66.
    View in: PubMed
    Score: 0.004
  15. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):8884-8.
    View in: PubMed
    Score: 0.004
  16. Oestrogen receptor activation in the absence of ligand. Biochem Soc Trans. 1995 Nov; 23(4):935-9.
    View in: PubMed
    Score: 0.003
  17. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A. 1993 Jul 01; 90(13):6120-4.
    View in: PubMed
    Score: 0.003
  18. Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity. J Med Chem. 2013 Apr 11; 56(7):2779-90.
    View in: PubMed
    Score: 0.003
  19. A Leu----His substitution at residue 93 in human corticosteroid binding globulin results in reduced affinity for cortisol. J Steroid Biochem Mol Biol. 1992 Aug; 42(7):671-6.
    View in: PubMed
    Score: 0.003
  20. Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol. 2010 Nov; 6(11):837-43.
    View in: PubMed
    Score: 0.002
  21. Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem. 2009 Dec 31; 10:36.
    View in: PubMed
    Score: 0.002
  22. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol Endocrinol. 1989 Nov; 3(11):1869-76.
    View in: PubMed
    Score: 0.002
  23. CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions. Nucleic Acids Res. 2009 May; 37(9):3110-23.
    View in: PubMed
    Score: 0.002
  24. The amino acid sequence of rat CBG deduced from a cDNA, and identification of CBG mRNA in the liver under different physiological states. Steroids. 1988 Oct; 52(4):331-2.
    View in: PubMed
    Score: 0.002
  25. Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens. J Steroid Biochem Mol Biol. 2006 May; 99(2-3):108-14.
    View in: PubMed
    Score: 0.002
  26. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol Cell Biol. 2005 Sep; 25(18):8273-84.
    View in: PubMed
    Score: 0.002
  27. SRC-1 is involved in the control of the gene expression of myelin protein Po. J Mol Neurosci. 2004; 24(2):217-26.
    View in: PubMed
    Score: 0.002
  28. Vector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089. Bone. 2002 Sep; 31(3):381-8.
    View in: PubMed
    Score: 0.001
  29. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Endocrinology. 2001 Sep; 142(9):3791-9.
    View in: PubMed
    Score: 0.001
  30. Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells. Mol Cell Endocrinol. 2001 Aug 20; 182(1):19-26.
    View in: PubMed
    Score: 0.001
  31. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol. 2001 Jan; 3(1):15-23.
    View in: PubMed
    Score: 0.001
  32. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell. 2000 Jun; 5(6):939-48.
    View in: PubMed
    Score: 0.001
  33. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol. 2000 Apr; 14(4):518-34.
    View in: PubMed
    Score: 0.001
  34. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A. 1999 Mar 02; 96(5):1858-62.
    View in: PubMed
    Score: 0.001
  35. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999 Feb; 19(2):1182-9.
    View in: PubMed
    Score: 0.001
  36. Functional subnuclear partitioning of transcription factors. J Cell Biochem. 1998 Aug 01; 70(2):213-21.
    View in: PubMed
    Score: 0.001
  37. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res. 1995; 50:333-47.
    View in: PubMed
    Score: 0.001
  38. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene. Contraception. 1994 Oct; 50(4):301-18.
    View in: PubMed
    Score: 0.001
  39. Squirrel monkey corticosteroid-binding globulin: primary structure and comparison with the human protein. Endocrinology. 1994 Feb; 134(2):891-8.
    View in: PubMed
    Score: 0.001
  40. Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J Steroid Biochem Mol Biol. 1991; 40(4-6):755-62.
    View in: PubMed
    Score: 0.001
  41. Interaction between corticosteroid binding globulin and activated leukocytes in vitro. Biochem Biophys Res Commun. 1990 Oct 15; 172(1):172-7.
    View in: PubMed
    Score: 0.001
  42. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab. 1990 Jul; 71(1):34-9.
    View in: PubMed
    Score: 0.001
  43. Corticosteroid binding globulin, testosterone-estradiol binding globulin, and androgen binding protein belong to protein families distinct from steroid receptors. J Steroid Biochem. 1988; 30(1-6):131-9.
    View in: PubMed
    Score: 0.001
  44. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5153-7.
    View in: PubMed
    Score: 0.000
  45. The cDNA-deduced primary structure of human sex hormone-binding globulin and location of its steroid-binding domain. FEBS Lett. 1987 May 04; 215(1):100-4.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.